| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/07/2003 | US6504020 Isolated nucleic acids comprising Listeria dal and dat genes |
| 01/07/2003 | US6503943 Antitumor agents |
| 01/07/2003 | US6503934 Substituted thiadiazolesulfonamides |
| 01/07/2003 | US6503919 Compounds of 7-oxo-2,3,7,14-tetrahydro-1H-benzo[b]pyrano[3,2-h]acridin carboxylate |
| 01/07/2003 | US6503914 Thienopyrimidine-based inhibitors of the Src family |
| 01/07/2003 | US6503910 Hydroxamic and carboxylic acid derivatives |
| 01/07/2003 | US6503908 Pharmaceutically active compounds |
| 01/07/2003 | US6503907 Indole and dihydroindole derivatives |
| 01/07/2003 | US6503893 Method of treating hyperproliferative diseases using active vitamin D analogues |
| 01/07/2003 | US6503889 Especially capecitabine, gemcitabine, CPT-11 or pemetrexed |
| 01/07/2003 | US6503888 AAV-mediated delivery of DNA to cells of the nervous system |
| 01/07/2003 | US6503733 Polynucleotides which identify and encode NANCH. The invention also provides genetically engineered expression vectors and host cells comprising the nucleic acid sequences encoding NANCH and a method for producing NANCH. Agonists, antibodies |
| 01/07/2003 | US6503713 Methods for identifying RNA binding compounds |
| 01/07/2003 | US6503513 Diagnostics and therapy of diseases associated with HHV-8 infections |
| 01/07/2003 | US6503510 As therapeutic agents for T cell tumors or B cell tumors (excluding myeloma) |
| 01/07/2003 | US6503505 Plant extract veterinary feed additive; food additive for enhancing weight gain in a recipient; Escherichia coli strain BU-230-98 ATCC Deposit No. 20226 (DSM 12799). |
| 01/07/2003 | CA2415199A1 Genes and their genetic products pertinent to microsatellite instable (msi+) tumours |
| 01/07/2003 | CA2228524C Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization and for treating human malignancies |
| 01/07/2003 | CA2149055C Antitumoral compositions containing taxan derivatives |
| 01/07/2003 | CA2113363C Process for constructing a cdna library and a novel polypeptide and dna coding the same |
| 01/07/2003 | CA2075590C Hydantoin derivatives |
| 01/07/2003 | CA2069154C Polypeptides |
| 01/05/2003 | CA2392189A1 Heterocyclo-alkylsulfonyl pyrazoles as anti-inflammatory/analgesic agents |
| 01/05/2003 | CA2390181A1 Sulfonyl aryl triazoles as anti-inflammatory/analgesic agents |
| 01/03/2003 | WO2003001212A2 A method for diagnosing a person having multiple sclerosis |
| 01/03/2003 | WO2003000928A2 Methods for identification of cancer cell surface molecules and cancer specific promoters, and therapeutic uses thereof |
| 01/03/2003 | WO2003000907A2 Improved transfection of eukaryotic cells with linear polynucleotides by electroporation |
| 01/03/2003 | WO2003000899A1 MUTANT FORMS OF EtxB AND CtxB AND THEIR USE AS CARRIERS |
| 01/03/2003 | WO2003000896A2 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-5 GENE |
| 01/03/2003 | WO2003000886A1 Novel g protein-coupled receptor protein and dna thereof |
| 01/03/2003 | WO2003000864A2 Nucleic acid-associated proteins |
| 01/03/2003 | WO2003000848A2 Liver engrafting cells, assays, and uses thereof |
| 01/03/2003 | WO2003000844A2 Protein modification and maintenance molecules |
| 01/03/2003 | WO2003000776A1 Biodegradable polyphosphoramidates for controlled release of bioactive substances |
| 01/03/2003 | WO2003000771A1 Block copolymer reduced in impurity content, polymeric carrier, pharmaceutical preparations in polymeric form and process for the preparation of the same |
| 01/03/2003 | WO2003000738A2 Water-soluble antibiotic comprising an amino sugar, in the form of a polysaccharide conjugate |
| 01/03/2003 | WO2003000736A1 Humanized antibodies derived from dd-3b6/22, specific for the d-dimer fragment of fibrin |
| 01/03/2003 | WO2003000709A2 Sialic acid derivatives for use as siglec inhibitors |
| 01/03/2003 | WO2003000695A1 Pyrrolopyrimidines as protein kinase inhibitors |
| 01/03/2003 | WO2003000688A1 Azaindoles |
| 01/03/2003 | WO2003000687A1 Tyrosine kinase inhibitors |
| 01/03/2003 | WO2003000684A1 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1) |
| 01/03/2003 | WO2003000678A1 Cyanoanthranilamide derivatives and the use thereof as medicaments |
| 01/03/2003 | WO2003000676A1 1,2,4-trioxolane antimalarials |
| 01/03/2003 | WO2003000671A1 Naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 01/03/2003 | WO2003000660A1 Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus proliferator receptor, and medicinal composition containing the same |
| 01/03/2003 | WO2003000656A2 Antisense modulation of transforming growth factor beta receptor ii expression |
| 01/03/2003 | WO2003000653A1 Substituted n-acyl aniline derivatives, production and use thereof as medicaments |
| 01/03/2003 | WO2003000647A1 (ethylene)-(propylene)-triaminepentaacetic acid derivatives, process for their production, and their use for the production of pharmaceutical agents |
| 01/03/2003 | WO2003000634A1 Vitamin d receptor antagonists and related compositions and methods of use |
| 01/03/2003 | WO2003000633A2 A process for the isolation of a major harmful oxidant from cigarette smoke |
| 01/03/2003 | WO2003000323A1 Safety shield system for prefilled syringes |
| 01/03/2003 | WO2003000322A1 Safety shield system for prefilled syringes |
| 01/03/2003 | WO2003000296A2 Treatment and diagnostic of b cell chronic lymphocytic leukaemia |
| 01/03/2003 | WO2003000290A1 Antitumor agents |
| 01/03/2003 | WO2003000286A1 Remedies for eosinophilic diseases |
| 01/03/2003 | WO2003000276A1 Anti-aromatase composition consisting of a mixture from plants extracts |
| 01/03/2003 | WO2003000238A1 Pharmaceutical compositions of adsorbates of amorphous drug |
| 01/03/2003 | WO2003000200A2 β-2'-OR 3'-HALONUCLEOSIDES |
| 01/03/2003 | WO2003000196A2 Pharmaceutical compositions which inhibit proliferation of pituitary adenomas and method of use thereof |
| 01/03/2003 | WO2003000194A2 Thienopyridine and thienopyrimidine anticancer agents |
| 01/03/2003 | WO2003000187A2 Novel pyrazolo-and pyrrolo-pyrimidines and uses thereof |
| 01/03/2003 | WO2003000185A2 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
| 01/03/2003 | WO2003000181A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 01/03/2003 | WO2003000180A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 01/03/2003 | WO2003000174A2 Compositions and methods for intracellular delivery |
| 01/03/2003 | WO2003000118A2 Method for enhancing the effectiveness of cancer therapies |
| 01/03/2003 | WO2003000117A2 Detection and treatment of prostate cancer |
| 01/03/2003 | WO2003000113A2 Compositions and methods for the diagnosis and treatment of tumor |
| 01/03/2003 | WO2003000024A2 Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection |
| 01/03/2003 | WO2003000023A2 Method of treating hyperproliferative diseases using active vitamin d analogues |
| 01/03/2003 | WO2003000021A2 Pancam nucleic acids and polypeptides |
| 01/03/2003 | WO2003000014A2 Spherical protein particles and methods of making and using them |
| 01/03/2003 | WO2003000012A2 Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast and ovarian cancer |
| 01/03/2003 | WO2003000011A2 Novel pyridopyrimidines and uses thereof |
| 01/03/2003 | WO2002083667A3 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 01/03/2003 | WO2002081661A3 Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides |
| 01/03/2003 | WO2002076484A3 Combination of a taxane and a cyclin-dependent kinase inhibitor |
| 01/03/2003 | WO2002060911A3 C-glucosyl ether lipids |
| 01/03/2003 | WO2002060868A3 Inhibitors of prenyl-protein transferase |
| 01/03/2003 | WO2002055676A3 Method for processing dendritic cells and for activating macrophages with ru 41740 |
| 01/03/2003 | WO2002048166A8 Indolocarbazole anticancer agents and methods of using them |
| 01/03/2003 | WO2002047673A3 Methods and compositions to treat conditions associated with neovascularization |
| 01/03/2003 | WO2002046170A8 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto |
| 01/03/2003 | WO2002045755A3 Expression of keratin genes 8 and 18 for treating tumours, in particular a mammary carcinoma |
| 01/03/2003 | WO2002044202A3 Mutated immunogenic peptides derived from r9m, polynucleotides coding for same and therapeutic uses thereof |
| 01/03/2003 | WO2002043647A3 Oncolytic virus |
| 01/03/2003 | WO2002034741A3 A NOVEL CRYSTALLINE FORM OF 6-HYDROXY-3-(4-[2-(PIPERIDIN-1-YL)ETHOXY]PHENOXY)-2-(4-METHOXYPHENYL)BENZO[b]THIOPHENE HYDROCHLORIDE |
| 01/03/2003 | WO2002026757A3 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 01/03/2003 | WO2002020620A3 Monoclonal antibody against ovarian carcinoma |
| 01/03/2003 | WO2002018536A3 Truncated bard1 protein, and its diagnostic and therapeutic uses |
| 01/03/2003 | WO2002016429A3 Compositions and methods for the diagnosis and treatment of tumor |
| 01/03/2003 | WO2002012501A3 Anti-dual integrin antibodies, compositions, methods and uses |
| 01/03/2003 | WO2002012329A3 Compositions and methods for the therapy and diagnosis of head and neck cancer |
| 01/03/2003 | WO2002010387A3 G-protein coupled receptors |
| 01/03/2003 | WO2002009715A3 Use of an arylaldehyde 5-oxo-1, 2, 4-triazine hydrazide for the treatment of cancer |
| 01/03/2003 | WO2002007759A3 Clostridial toxin derivatives and methods for treating pain |
| 01/03/2003 | WO2002005791A3 Antitumor combination comprising an aromatase inhibitor and an egfr antagonist or inhibitor |
| 01/03/2003 | WO2002004611A3 Aminoacyl trna synthetases |
| 01/03/2003 | WO2002003976A3 Combinations of bisphosphonates, estrogenic agents and optionally estrogens |